Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 12.33
-0.29 (-2.30%)
At close: Aug 11, 2026
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 5.02 billion as of August 11, 2026. Its market cap has increased by 73.83% in one year.
Market Cap
5.02B
Enterprise Value
5.00B
Revenue
656.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.33
ChartMarket Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 5.02B, an increase of 109.29%. That is a compound annual growth rate of 17.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 5.02B | -48.28% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.87B |
| Shanghai Runda Medical Technology | 6.36B |
| Maccura Biotechnology Co.Ltd | 5.65B |
| Thalys Medical Technology Group | 3.85B |
| Shanghai Labway Clinical Laboratory | 3.77B |
| SMO ClinPlus CO.,LTD. | 3.73B |
| Guangdong Hybribio Biotech | 3.67B |